Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer

Clinical trial NCT07498400 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07498400
Sponsor: Xijing Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer (Triple Negative Breast Cancer (TNBC))Breast Cancer

Start date: 2026-01-01
Primary completion: 2030-12-31
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.